COST-UTILITY ANALYSIS OF IMMUNE TOLERANCE INDUCTION (ITI) THERAPY VERSUS ON-DEMAND TREATMENT WITH RECOMBINANT FVII (RFVIIA) FOR HEMOPHILIA A WITH HIGH TITER INHIBITORS IN IRAN

View/Open

1-s2.0-S1098301512021742-main.pdf (54.07Kb)

Date

2012

Author

Imani, A

Rasekh, H

Golestani, M

Metadata

Show full item record

URI

http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49539

Collections

• Published Articles